Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ITS ONLY UP FROM HERE. BAYER HAS ASSURED EASTON SUCCESS.
BAYER PHARMA HAS SIGNED A DEAL WITH EASTON / BMV
THERE IS NO LONGER ANY RISK WITH EASTON. FOR THOSE WHO DONT UNDERSTAND, A MULTI-NATIONAL COMPANY WITH A MARKET CAP OF OVER 200 BILLION DOLLARS JUST SIGNED A DISTRIBUTION AGREEMENT WITH EASTON AND BMV. BAYER HAS 100,000 EMPLOYEES AND A SALES FORCE THAT IS HUGE. THOSE TYPE OF COMPANYS DO NOT SELL ANY PRODUCTS WITHOUT KNOWING AND EXPECTING TO SELL TENS OF MILLIONS.
ROYALTIES FROM BAYER! ROYALTIES FROM BAYER! ROYALTIES FROM BAYER! ROYALTIES FROM BAYER!
THAT IS ALL THAT NEEDS TO BE SAID.
LONG AND STRONG
SOON WE WILL GET UPDATES ON REVENUES FROM THE ALLIANCE ACQUISITION. EASTON HAS SHOWN THAT PAYING AND INVESTING IS WOMANS DIAGNOSTIC PRODUCTS HAS NOW DELIVERED A BIG FISH IN BAYER AS A PARTNER. BAYER DOES NOT GET INTO SELLING ANY PRODUCTS UNLESS THEIR ARE MILLIONS OF DOLLARS TO BE MADE.
CAN ANYONE SAY ROYALTIES.
NEW INVESTORS AND INVESTMENT GROUPS ARE COMING ON BOARD. WERE PASSED 40.03 CENTS A SHARE AND LOTS MORE TO COME. IT WILL BE A SLOW AND STEADY CLIMB UP FROM HERE AS THE WORD GETS OUT ABOUT BAYER PHARMACEUTICALLS. A COMPANY WITH A MARKET CAP OF OVER $200 BILLION AND HAVING 100,000 EMPLOYEES.
GO EAPH GO
LONG and STRONG...GO EAPH GO
Even after news of a major super giant multi0national company doing business with Easton and its partner BMV Medica called BAYER, there are still the same fools typing the same garbage. BAYER has 100,000 employees and has allowed Easton / BMV to put their name on a press release as well as their website. That demonstrates they have a real product. The business decision to pay cash for womans diagnostic products through licensing has paid off.
Don't listen to anyone here but only press releases and the company. Call them. email them and read the news. Thats what you need to know.
LONG and STRONG
50% Return in 2 weeks. It took Apple 2 years to do that in a bull market. Wait till revenues start to come in from Alliance Group. $.20cents is just the start.
BIG SMART MONEY IS COMING IN. SMALL SHORT PULLBACK ON THE WAY TO NEW HIGHS. ALLIANCE CONTRACTS TO DELIVER BIG PROFITS FOR EASTON AND SHAREHOLDERS. BAYER PHARMACEUTICALS TO DELIVER HUGE PROFITS FOR SHAREHOLDERS.
Easton in the past week has provided new shareholders with a 50% profit which is more than Apple has done . Easton will soon have the same market cap as medical marijuana or MJNA. This company is so undervalued that it’s no longer funny. But it soon will be after the stock plows through $.10 cents and higher. Consistent revenues and contracts with Bayer soon to be disclosed. Easton will soon fly away to the moon and if you don’t grab it now then your loss.
EASTON HAS A PARTNER WITH 11,000 EMPLOYEES AND REVENUES IN THE BILLIONS. THEY ARE WITHIN A FEW DAYS OF ANNOUNCING WHAT I BELIEVE IS BAYER PHARMACEUTICALS AS A PARTNER.
LETS LOOK AT THE ACCOMPLISHMENTS THAT THEY HAVE MADE WITH EVAN KARRAS AT THE HELM
1) THEY HAVE RAISED MILLIONS OF DOLLARS WITH ZERO DILUTION OVER THE PAST 3 YEARS.
2) THEY INVESTED THOSE FUNDS RAISED TOWARDS PAYING OFF AND ACQUIRING ALLIANCE GROUP WHICH WILL START TO GENERATE REVENUES IN THE NEXT 14 DAYS AS OPERATIONS COMMENCE WITH AGGREGATE BUSINESS WHICH IS A CASH COW BUSINESS
3)THEY PAID OVER A MILLION DOLLARS FOR LICENCE RIGHTS FOR WOMAND DIAGNOSTIC AND TREATMENT PRODUCTS. THAT HAS NOW STARTED TO EARN REVENUES THROUGH THEIR SUB-DISTRIBUTION PARTNER GEDEON RICHTER WHO HAVE 11,000 EMPLOYEES.
4) THEY ARE NOW STARTING SALES WITH WINDSOR PHARMACEUTICALS AS WINDSOR HAS OBTAINED APPROVAL TO SELL THE PRODUCTS IN LATIN AMERICA.
5) THEY CLOSED WITH IBLISS BUT A DELAY IN PAYING OUT CASH AS A RESULT OF THAT CASH BEING USED FOR ALLIANCE WILL SOON BE SORTED OUT.
6) A DEAL WITH BAYER IS A FEW DAYS AWAY
THE FUTURE IS VERY BRIGHT AND THE STOCK IS HUGELY UNDERVALUED
EASTON HAS ZERO DILUTION IN 3 YEARS AND THEY HAVE PROPERTY VALUED AT $4,000,000. LETS LOOK AT THE ACCOMPLISHMENTS THAT THEY HAVE MADE WITH EVAN KARRAS AT THE HELM
1) THEY HAVE RAISED MILLIONS OF DOLLARS WITH ZERO DILUTION OVER THE PAST 3 YEARS.
2) THEY INVESTED THOSE FUNDS RAISED TOWARDS PAYING OFF AND ACQUIRING ALLIANCE GROUP WHICH WILL START TO GENERATE REVENUES IN THE NEXT 14 DAYS AS OPERATIONS COMMENCE WITH AGGREGATE BUSINESS WHICH IS A CASH COW BUSINESS
3)THEY PAID OVER A MILLION DOLLARS FOR LICENCE RIGHTS FOR WOMAND DIAGNOSTIC AND TREATMENT PRODUCTS. THAT HAS NOW STARTED TO EARN REVENUES THROUGH THEIR SUB-DISTRIBUTION PARTNER GEDEON RICHTER WHO HAVE 11,000 EMPLOYEES.
4) THEY ARE NOW STARTING SALES WITH WINDSOR PHARMACEUTICALS AS WINDSOR HAS OBTAINED APPROVAL TO SELL THE PRODUCTS IN LATIN AMERICA.
5) THEY CLOSED WITH IBLISS BUT A DELAY IN PAYING OUT CASH AS A RESULT OF THAT CASH BEING USED FOR ALLIANCE WILL SOON BE SORTED OUT.
6) A DEAL WITH BAYER IS A FEW DAYS AWAY
THE FUTURE IS VERY BRIGHT AND THE STOCK IS HUGELY UNDERVALUED
NO MATTER HOW MUCH THEY SHOUT, REAL INVESTORS ARE NOT GOING TO BE PERSUADED TO BELIEVING THAT THE COMPANY IS NOT DOING A GREAT JOB IN MOVING FORWARD. NO ONE IS LISTENING TO THEM AS THATS WHY THE STOCK IS STILL AT THE $.-2 CENT RANE AND NOT THE $0.0002 RANGE LIKE THEY HOPE.
ZERO DILUTION FOR FINANCING IN OVER 3 YEARS.
1) THEY HAVE RAISED MILLIONS OF DOLLARS WITH ZERO DILUTION OVER THE PAST 3 YEARS.
2) THEY INVESTED THOSE FUNDS RAISED TOWARDS PAYING OFF AND ACQUIRING ALLIANCE GROUP WHICH WILL START TO GENERATE REVENUES IN THE NEXT 14 DAYS AS OPERATIONS COMMENCE WITH AGGREGATE BUSINESS WHICH IS A CASH COW BUSINESS
3)THEY PAID OVER A MILLION DOLLARS FOR LICENCE RIGHTS FOR WOMAND DIAGNOSTIC AND TREATMENT PRODUCTS. THAT HAS NOW STARTED TO EARN REVENUES THROUGH THEIR SUB-DISTRIBUTION PARTNER GEDEON RICHTER WHO HAVE 11,000 EMPLOYEES.
4) THEY ARE NOW STARTING SALES WITH WINDSOR PHARMACEUTICALS AS WINDSOR HAS OBTAINED APPROVAL TO SELL THE PRODUCTS IN LATIN AMERICA.
5) THEY CLOSED WITH IBLISS BUT A DELAY IN PAYING OUT CASH AS A RESULT OF THAT CASH BEING USED FOR ALLIANCE WILL SOON BE SORTED OUT.
6) A DEAL WITH BAYER IS A FEW DAYS AWAY
THE FUTURE IS VERY BRIGHT AND THE STOCK IS HUGELY UNDERVALUED
ZERO DILUTION WHILE THEY HAVE RAISED MILLIONS IN FINANCING. NOT ONW NEW SHARE ISSUED FROM FINANCINGS IN THE LAST 3 YEARS. NOW THAT IS WHAT ANYONE WOULD CALL A FANTASTIC FEAT FOR ALL SHAREHOLDERS. WHAT EVENTUALLY THEY WILL HAVE TO ISSUE SHARES BUT MOST OF THE FINANCING WAS DONE THROUGH MORTGAGES ON SOLID ASSETS SUCH AS PROPERTY.
EASTON IS WAY UNDERVALUED BUT IT WONT BE FOR LONG
EASTON HAS FORWARDED OTCQX LISTING DOCUMENTS TO OTC MARKETS. AN UPLISTING IS IMMINENT
BAYER PHARMACEUTICALS ANNOUNCEMENT IS IMMINENET AND WILL BE THE CATALYST TO CATAPULT THE STOCK TO 52 WEEK HIGHS. THE AGREEMENT HAS RECEIVED APPROVAL AND IS AWAITING JUST ONE SIGNATURE FROM BASEL .
LONG AND STRONG!
EASTON IS MOVING ALONG VERY WELL WITH ITS BUSINESS. LETS LOOK AT THE ACCOMPLISHMENTS THAT THEY HAVE MADE WITH EVAN KARRAS AT THE HELM
1) THEY HAVE RAISED MILLIONS OF DOLLARS WITH ZERO DILUTION OVER THE PAST 3 YEARS.
2) THEY INVESTED THOSE FUNDS RAISED TOWARDS PAYING OFF AND ACQUIRING ALLIANCE GROUP WHICH WILL START TO GENERATE REVENUES IN THE NEXT 14 DAYS AS OPERATIONS COMMENCE WITH AGGREGATE BUSINESS WHICH IS A CASH COW BUSINESS
3)THEY PAID OVER A MILLION DOLLARS FOR LICENCE RIGHTS FOR WOMAND DIAGNOSTIC AND TREATMENT PRODUCTS. THAT HAS NOW STARTED TO EARN REVENUES THROUGH THEIR SUB-DISTRIBUTION PARTNER GEDEON RICHTER WHO HAVE 11,000 EMPLOYEES.
4) THEY ARE NOW STARTING SALES WITH WINDSOR PHARMACEUTICALS AS WINDSOR HAS OBTAINED APPROVAL TO SELL THE PRODUCTS IN LATIN AMERICA.
5) THEY CLOSED WITH IBLISS BUT A DELAY IN PAYING OUT CASH AS A RESULT OF THAT CASH BEING USED FOR ALLIANCE WILL SOON BE SORTED OUT.
6) A DEAL WITH BAYER IS A FEW DAYS AWAY
THE FUTURE IS VERY BRIGHT AND THE STOCK IS HUGELY UNDERVALUED
BIG INVESTMENT GROUPS AND THEIR THOUSANDS OF TWITTER FOLLOWERS GETTING READY TO START BUYING BIG BLOCKS VERY SHORTLY. I AM NOT ALLOWED TO SAY WHICH ONE BUT OUR GROUP KNOWS THAT 2 TO 3 LARGE BUYING GROUPS WILL SOON BE BUYING. GOOD DAYS ARE SOON COMING BACK.
MARIJUANA OR NO MARIJUANA. EASTON HAS REVENUES STARTING IN 2 WEEKS WITH ALLIANCE GROUP. $6,000,000 CONTRACT IN HAND. DONE FOCUS ON MARIJUANA BUT FOCUS ON SALES. BIG REVENUES SOON TO START WITH ALLIANCE. THEY ALSO HAVE AN $8,000,000 PROPERTY ASSET SO INVESTORS SHOULD NOT FOCUS ON MARIJUANA AS THAT IS SECONDARY. THE BIG PROFITS COME FROM ALLIANCES OTHER PROPERTIES. NO COMPANY PAYS $1,300,000 TO HAVE IT SIT.
LONG AND STRONG
EASTON WILL VERY SHORTLY NOT BE UNDERVALUED. REVENUES TO START IN 2 WEEKS WITH ALLIANCE GROUP. REVENUES HAVE ALREADY STARTED WITH GEDEON RICHTER. REVENUES TO SOON START WITH BAYER PHARMACEUTICALS.
EVERY STOCK HAS ITS TIME AND EASTONS TIME IS SOON AT HAND. ONCE REVENUES START WITHIN THE NEXT 2 TO 3 WEEKS WITH ALLIANCE, SHAREHOLDERS WILL BE VERY PLEASED TO SEE WHAT HAPPENS.
EASTON IS WAY UNDERVALUED BUT NOT FOR LONG.
LONG AND STRONG
EASTON HAS ALREADY HAD INTERVIEWS WITH FINRA ON ITS PRESS RELEASES. EVERYTHING POSTED BY THE COMPANY HAS BEEN REVIEWED.
NOTHING POSTED BY EASTON IS DISPUTED AND DOES ANYONE BELIEVE THAT EASTON WOULD TAKE A CHANCE ON POSTING SOMETHING THAT WOULD MAKE ANYONE HAVE LIABILITIES. GEDEON RICHTER IS A REAL COMPANY WHO HAVE PURCHASED PRODUCT FROM EASTON WHO HAVE 11 MILLION EMPLOYEES WORLDWIDE. YET THEY ALLOWED A PRESS RELEASE TO BE RELEASED BY EASTON USING GEDEONS NAME.
EASTON JUST PURCHASED PROPERTY VALUED AT $8,000,000 CDN. IN 2 WEEKS REVENUES WILL SOON BE STARTING WITH ALLIANCE CONTRACTS.
READ EASTONS FINANCIAL STATEMENTS TO SEE HOW MUCH MONEY THEY HAVE RAISED AND HOW MUCH HAS BEEN SPENT ON ACQUISITIONS AND LICENSES.
LONG AND STRONG
!!!!!BAYER PHARMACEUTICALS & EASTON DEAL IS SOON AT HAND!!!EASTON IS A LONG TERM BUY AND HOLD. THEY HAVE COLD HARD CASH INVESTED INTO ACQUISITIONS AND HAVE ACQUIRED THE RIGHTS TO WOMAND HEALTH PRODUCTS. 2 PRODUCTS ARE CURRENTLY SELLING WHICH ARE AMNIOSENSE AND GYNOFIT. A THIRD PRODUCT IS SOON AT HAND THROUGH BAYER PHARMACEUTICALS. ITS JUST DAYS AWAY AND WHEN THAT IS ANNOUNCED THEN NO ONE WILL EVER DISPUTE ANYTHING WITH THIS COMPANY
To All Shareholders and Investors. Todays fantastic press release by EAPH will soon be recognized by all investors and new investors who will soon buy the stock up to new highs. Easton management does not believe in pump and dumps and does not pay any IR companies as they prefer to grow their business than artificially increase it through unscrupulous investor relations firms. But Easton will soon be featured and will have its CEO Evan Karras interviewed on a large Canadian TV show for public companies. This will get traction and get it all started. Its just a matter of time that Easton will once again be the darling of the OTC Markets exchange
EAPH looking good heading into the weekend, next couple days IMO should bring some good volume hopefully
After Several Months, #EAPH Easton Receives Final Agreement For Review From Multi-National Pharma Company For Third Product Launch.
EAPH is really undervalued IMO
EAPH has HUGE news looming, time to accumulate
$EAPH UP ALMOST 12% MID-DAY PPS SET TO GO MUCH HIGHER
EAPH's PPS will be way up this time next year great long term buy here
Read today's press release from $EAPH Easton Pharmaceuticals @EastonPharma here https://goo.gl/JW34kq #News #PressRelease #EAPH
EAPH should have a great day agreed
Easton Pharmaceuticals Announces That Its Partner Windsor Pharmaceuticals Has Received Regulatory Approvals For Products VS-Sense and AL-Sense For Central America and The Caribbean https://goo.gl/JW34kq
#News #PressRelease #EAPH
I sense a lot of new bids coming in today for EAPH
EAPH might have a license sooner then most think. Health Canada is demonstrating that it is committed to ramping up the licensing process, as it had committed to do doing so in May of this year.
Health Canada announced in May of this year that it was streamlining the process for applicants to obtain commercial licensed producer licenses. While licensees will still have to go through lengthy processes, the security clearance review that often hangs in the shadows for applicants will now take place at the same time as the detailed review stage.
Great move for EAPH ahead of next year's full legalization in canada, huge profits ahead!
EAPH should have no trouble breaking resistance I see great value here well above .03
The entire week is looking good for EAPH, from todays PR : "Easton Pharmaceuticals will provide an update in the coming days toward its previous announcement of a possible launch of a third product through the closing of a third sub-distribution agreement with a Switzerland based multi-national drug company."
Now that's what I think we have all been waiting for
Easton Pharmaceuticals Announces $1,000,000 cdn In Payments Toward Alliance Group JV / Partnership Agreement; Announces $8,000,000 cdn Aggregate LOI Contract
TORONTO, ON--(Marketwired - Sep 5, 2017) - Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), is pleased to announce, pursuant to its previously announced Closing Agreement with Canadian based 124123 Ontario Inc. (O/A - Alliance Group), Easton has advanced $1,000,000 cdn in payments to Alliance Group. Alliance executes $8,000,000 cdn aggregate LOI contract on its 90 acres of zoned industrial land.
Easton Pharmaceuticals has thus far paid $1,000,000 cdn in cash out of $1.3 million cdn to Toronto based 124123 Ontario Inc. (o/a - Alliance Group) to acquire a 50% property ownership interest in 45 acres of agriculturally zoned land north of Toronto, Ontario, Canada and into a business to cultivate, produce and facilitate the sale of its production of medical / recreational marijuana and other revenue producing businesses on a co-managed basis. Alliance has initiated the process to legally grow medical / recreational marijuana with all levels of government in Canada including federal and provincial ministers, municipal governments and law enforcement officials. Alliance anticipates positive news within the next 30 to 45 days regarding its medical / recreational marijuana license exemptions. At Easton option, until such time that approvals and revenues can be legally generated with cultivating and distributing medical / recreational marijuana in Canada, the agreement calls for Easton to receive 50% of all revenues on Alliance's Aggregate businesses, which includes recycling, manufacturing of various industrial products, waste management services, cement, asphalt and other type aggregate products. Alliance Partners announces that it signed a letter of intent for an approximate $8,000,000 cdn contract with a local construction company which will convert to a final closing agreement once environmental and soil analysis samples have completed testing. Alliance is anticipating and planning for a closed contract by September 30th of this year, but delays in samples may extend this time frame.
In other developments, Easton Pharmaceuticals will provide an update in the coming days toward its previous announcement of a possible launch of a third product through the closing of a third sub-distribution agreement with a Switzerland based multi-national drug company.
About Easton Pharmaceuticals
Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. The Company previously developed and owned an FDA-approved wound-healing medical drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton has partnered with BMV Medica and together own the exclusive distribution rights in Mexico and Latin America for patented women's diagnostic / treatment products "Gynofit," "AmnioSense," "VS-Sense" and two generic cancer drugs " Docetaxel" Paclitaxel." Easton / BMV have sub-licensed products "Gynofit" and "AmnioSense" with multi-national pharmaceutical company Gedeon Richter Plc of Hungary. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of other drugs and Cannabidiol extracts. Easton has closed on an agreement to acquire 100% of iBliss Inc., a leading e-liquid vapour producer and distributor with international sales and has entered into a 50 / 50 JV Partnership agreement with Alliance Partners to cultivate, grow, harvest, distribute and sell medical / recreational marijuana for Canada.
For More Information On Easton and Affiliated and Partner Company's Visit:
http://www.eastonpharmaceuticalsinc.com
http://www.richter.hu/en-US/Pages/default.aspx
http://www.bmvmedica.net
http://iblissvapor.com
http://finance.yahoo.com/q?s=eaph
https://twitter.com/eastonpharma
Safe Harbor
This news release may contain forward-looking statements or expressions within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when certain words or phrases such as "hope," "positive," "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are expressed, they are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals may contain risks. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.
Contact Information
Easton Pharmaceuticals
Evan Karras
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192
Email: info@eastonpharmaceuticalsinc.com
EAPH has lots of new revenue streams they are doing a great job, great info thanks for sharing
This is going to be an exciting week for EAPH
All good things to come in time and EAPH is working hard to bring good value IMO just keep accumulating and you will benefit BIG TIME!